SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (267)5/1/2003 7:14:58 PM
From: muddphudd  Read Replies (1) | Respond to of 371
 
Hi,

I am new to IMMU. I friend of mine just recently interviewed there for a position and was very impressed by the facility and the products, especially the data on CD22. How much did they leverage to AMGEN? What do they get in return if the product is eventually approved?
Thanks,
Ron